drugset / Trial / NCT03802864
Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine
Phase 4
Completed
50 enrolled
Weill Medical College of Cornell University
Pacira Pharmaceuticals, Inc · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.
Timeline
- Start
- 2019-02-04
- Primary completion
- 2020-01-30
- Completion
- 2020-01-30
Outcome
Missed primary endpoint
registry analysis (superiority test); Liposomal Bupivacaine vs Standard Bupivacaine; p = 0.41; t-test, 2 sided NCT03802864 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 50 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 100 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |